Yet such case studies can only ever provide circumstantial evidence that
seeds of amyloid - β were transferred during the treatments.
«It is the best source of fresh human brain tissue available at the moment,» says Jucker, who plans to scrutinize it carefully under the microscope for anything that might resemble tiny clumps or
seeds of amyloid - β.
Not exact matches
Collinge has access to some original samples
of growth hormone stored by the UK Department
of Health, and he is planning to analyse them for the presence
of amyloid seeds and then inject them into mice.
Knowing the structures
of pathological forms
of amyloid seeds should help to design small molecules that bind to them and stop them doing damage, says biophysicist Ronald Melki at the Paris - Saclay Institute
of Neuroscience, who works on α - synuclein strains.
A decade ago, these similarities prompted neuroscientist Mathias Jucker at the University
of Tübingen in Germany to test whether injecting brain extracts containing misfolded
amyloid - β into mice could
seed an abnormal build - up
of amyloid in the animals» brains.
Jucker, only half - jokingly, says he could imagine a future in which people would go into hospital every ten years or so and get the
amyloid seeds cleared out
of their brains with antibodies.
Researchers are also trying to work out what the putative
amyloid seeds look like, and whether different «strains»
of amyloids exist that are particularly damaging.
These results suggest that material containing aggregated IAPP
seeds can induce the aggregation and deposition
of new IAPP
amyloid in cultured islets and that the formation
of new
amyloid deposits depends on the expression
of endogenous hIAPP in the islets.
Dissociation
of prion protein
amyloid seeding from transmission
of a spongiform encephalopathy
On that list is Vitamin E, a powerful antioxidant found in oils, nuts,
seeds, whole grains and leafy green vegetables, which is associated with slower cognitive decline, a lower risk
of dementia, and reduced accumulation
of beta -
amyloid proteins — a key culprit in Alzheimer's disease.
In the case
of the eight patients in the study, Collinge said that it's likely they acquired a-beta
amyloid seeds from the hormone harvested from the deceased elderly who donated their organs for that purpose.
Collinge admitted that more research needs to be done to fully understand how important a pathway the
amyloid seeds might be in contributing to Alzheimer's, but that the latest results highlight «the growing paradigm shift in understanding that neurodegenerative disease [like Alzheimer's and Parkinson's] may be all about accumulation
of [prion]
seeds.»